BSE Live
Nov 04, 12:40Prev. Close
432.05
Open Price
429.25
Bid Price (Qty.)
440.85 (6)
Offer Price (Qty.)
442.05 (13)
NSE Live
Nov 04, 12:40Prev. Close
431.85
Open Price
430.00
Bid Price (Qty.)
441.20 (341)
Offer Price (Qty.)
441.65 (1)
| Key Financial Ratios of Panacea Biotec (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -2.49 | 0.58 | -14.29 | -15.28 | -2.35 | |
| Diluted EPS (Rs.) | -2.49 | 0.58 | -14.29 | -15.28 | -2.35 | |
| Cash EPS (Rs.) | 0.83 | 4.02 | -10.29 | -10.96 | 1.98 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 51.22 | 50.20 | 49.63 | 64.24 | 79.43 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 51.22 | 50.20 | 49.63 | 64.24 | 79.43 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 50.55 | 58.71 | 41.97 | 38.45 | 56.09 | |
| PBDIT/Share (Rs.) | 1.58 | 6.38 | -4.60 | -9.81 | 3.47 | |
| PBIT/Share (Rs.) | -1.73 | 2.94 | -8.60 | -14.13 | -0.87 | |
| PBT/Share (Rs.) | -4.25 | 0.69 | -10.25 | -15.28 | -2.10 | |
| Net Profit/Share (Rs.) | -2.48 | 0.58 | -14.29 | -15.28 | -2.36 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 3.12 | 10.86 | -10.96 | -25.52 | 6.18 | |
| PBIT Margin (%) | -3.42 | 5.00 | -20.49 | -36.74 | -1.55 | |
| PBT Margin (%) | -8.41 | 1.16 | -24.41 | -39.73 | -3.74 | |
| Net Profit Margin (%) | -4.91 | 0.98 | -34.05 | -39.73 | -4.20 | |
| Return on Networth / Equity (%) | -4.85 | 1.15 | -28.79 | -23.78 | -2.96 | |
| Return on Capital Employed (%) | -2.04 | 3.56 | -11.18 | -16.79 | -0.90 | |
| Return on Assets (%) | -1.75 | 0.47 | -12.09 | -12.28 | -1.82 | |
| Total Debt/Equity (X) | 0.73 | 0.39 | 0.32 | 0.20 | 0.12 | |
| Asset Turnover Ratio (%) | 0.38 | 0.49 | 0.35 | 0.30 | 43.40 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.84 | 0.74 | 0.81 | 1.17 | 1.46 | |
| Quick Ratio (X) | 0.40 | 0.30 | 0.35 | 0.65 | 1.02 | |
| Inventory Turnover Ratio (X) | 0.95 | 1.11 | 1.07 | 1.59 | 3.95 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,867.47 | 838.39 | 722.84 | 949.50 | 1,059.69 | |
| EV/Net Operating Revenue (X) | 9.25 | 2.33 | 2.81 | 4.03 | 3.08 | |
| EV/EBITDA (X) | 295.92 | 21.46 | -25.64 | -15.80 | 49.90 | |
| MarketCap/Net Operating Revenue (X) | 8.72 | 2.07 | 2.58 | 3.86 | 3.16 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 8.60 | 2.42 | 2.18 | 2.31 | 2.23 | |
| Price/Net Operating Revenue | 8.72 | 2.07 | 2.58 | 3.86 | 3.16 | |
| Earnings Yield | -0.01 | 0.00 | -0.13 | -0.10 | -0.01 | 
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y